Health In Tech (NASDAQ:HIT) Director Timothy Hayes Sells 12,000 Shares

Health In Tech, Inc. (NASDAQ:HIT) Director Timothy Hayes sold 12,000 shares of the company’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $0.91, for a total transaction of $10,920.00. Following the completion of the sale, the director owned 120,780 shares in the company, valued at approximately $109,909.80. This trade represents a 9.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Timothy Hayes also recently made the following trade(s):

• On Wednesday, September 9th, Timothy Hayes sold 5,730 shares of Health In Tech stock. The shares were sold at an average price of $0.93, for a total value of $5,328.90.

Health In Tech Stock Down 2.7%

Shares of NASDAQ HIT opened at $0.91 on Friday. The stock’s 50 day moving average price is $1.04 and its two-hundred day moving average price is $1.23. Health In Tech, Inc. has a 52-week low of $0.85 and a 52-week high of $4.02. The stock has a market capitalization of $59.36 million, a P/E ratio of -12.94 and a beta of 2.72.

Health In Tech (NASDAQ:HIT) last issued its earnings results on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The firm had revenue of $8.06 million during the quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HIT. Weiss Ratings restated a “sell (d)” rating on shares of Health In Tech in a research report on Tuesday, June 30th. Maxim Group lowered their price objective on shares of Health In Tech from $4.00 to $3.00 and set a “buy” rating for the company in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Health In Tech has an average rating of “Moderate Buy” and an average target price of $3.50.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Whetstone Capital Advisors LLC acquired a new position in shares of Health In Tech during the second quarter worth approximately $1,525,000. Renaissance Technologies LLC acquired a new position in Health In Tech during the 4th quarter worth $214,000. XTX Topco Ltd bought a new stake in shares of Health In Tech during the fourth quarter valued at about $203,000. Ancora Advisors LLC acquired a new stake in Health In Tech in the third quarter worth about $389,000. Finally, Two Sigma Investments LP bought a new position in Health In Tech in the 3rd quarter valued at about $386,000.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.